ISOLX | LIRIX | ISOLX / LIRIX | |
Total Expense Ratio | 0.40 | 0.14 | 286% |
Annual Report Gross Expense Ratio | 0.41 | 0.18 | 228% |
Fund Existence | 12 years | 14 years | - |
Gain YTD | 0.854 | 1.307 | 65% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250000 | 2000000 | 13% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 103M | 13.2B | 1% |
Annual Yield % from dividends | 2.34 | 2.87 | 81% |
Returns for 1 year | 7.74 | 8.39 | 92% |
Returns for 3 years | 12.51 | 14.28 | 88% |
Returns for 5 years | 12.17 | 23.01 | 53% |
Returns for 10 years | 23.88 | 48.54 | 49% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FTANX | 11.84 | N/A | N/A |
Fidelity Asset Manager 30% | |||
MICIX | 8.64 | N/A | N/A |
Victory Trivalent Intl Fd-Core Eq I | |||
FRBRX | 121.30 | N/A | N/A |
Franklin Biotechnology Discovery R6 | |||
FZAIX | 51.30 | N/A | N/A |
Fidelity Advisor International Discv Z | |||
BISLX | 11.34 | N/A | N/A |
Brown Advisory Sustainable Intl Ldrs Inv |